Vol 56, No 5 (2005)
Original paper
Published online: 2006-05-28
Clinical course and treatment of patients with differentiated
Endokrynol Pol 2005;56(5):758-765.
Abstract
The aim of the study was to analyze the clinical course
and therapy in patients with differentiated thyroid
carcinoma (DTC) diagnosed in Poland within the year
1995. The group of 478 patients with thyroid cancer
(57.7% of all thyroid cancer cases diagnosed this year in
Poland) was analyzed. Patients were diagnosed or treated
in Maria Skłodowska-Curie Memorial Cancer Center and
Institute of Oncology, Gliwice Branch. Detailed analysis
was performed in 352 patients with DTC who were
treated by surgery. 292 patients (60%) received adjuvant
radioiodine therapy. Hormonal (L-thyroxine) treatment
was administered to all patients. In 37 patients (8.6%)
local recurrence was observed. 10-year overall survival
was 96.4% and disease-free survival was respectively
68%. The comparison of Polish data to analysis in German
population published by Holtzer et al. (Cancer, 2000) was
also performed in this study.
We conclude that DTC therapy, currently
recommended in our country, gives satisfactory results
and that clinical outcome and therapeutic methods are
similar both in Poland and Germany.
Keywords: differentiated thyroid cancercombined therapy
![](https://journals.viamedica.pl/plugins/generic/popups/images/icons/close.png)